EN
|
LT
| Trade mark | ||
|---|---|---|
| (210) | Application number | 98-0294 |
| (220) | Date of filing the application | 1998-01-27 |
| (111) | Registration number | 36731 |
| (151) | Registration date | 2000-01-13 |
| (181) | Expire | 2028-01-27 |
| (450) | Date of registration publication, bulletin No. | 2000-02-25, 2000/2 |
| Legal status |
Registered
|
|
| Reproduction of the mark | ||
| (540) | WELLBUTRIN SR | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmacijos preparatai ir medžiagos (centrinei nervų sistemai gydyti ir/ar ligų profilaktikai, ir pagalbai buvusiems rūkytojams); antidepresiniai farmacijos preparatai ir medžiagos. |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | GLAXO GROUP LIMITED |
| Address | GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY | |
| Country | GB | |
| Attorney or representative | ||
| (740) | Name | Jurga Petniūnaitė |
| Address | AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||